bioRxiv Science⌕ Search

bioRxiv · 10.1101/2025.10.02.679973

Metabolism-weighted brain connectome reveals synaptic integration and vulnerability to neurodegeneration

Abstract

The brains capacity for integration arises from both its structural wiring and energetically demanding electrochemical signaling. Yet current connectome analyses treat network nodes as functionally homogeneous, ignoring that neural communication is constrained by metabolic cost. Here we introduce a metabolism-weighted connectome, a fully weighted brain graph in which both connections and the metabolic activity of each node describe the networks capacity for integration. Using three datasets of simultaneous fMRI and FDG-PET acquisitions, we define metabolism-weighted centrality (MwC), a biologically grounded index of each regions signaling dominance that integrates functional connectivity (FC) with local energy metabolism. MwC provides a more accurate representation of cortical activity flow than classical edge-based metrics and reveals that metabolically active hubs align with higher-order cognitive networks. Transcriptomic and synaptic imaging data demonstrate that these hubs exhibit increased synaptic energy turnover, linking activity-driven centrality to the molecular architecture of signaling. Notably, the same high-MwC regions show greater susceptibility to neurodegenerative pathology, suggesting that lifelong metabolic demand influences both integrative function and disease vulnerability. By linking neuronal metabolism to network organization, our framework bridges cellular energetics and system-level computation, opening new avenues for interpreting brain vulnerability and performance. Significance StatementThe various regions of the brain exhibit unequal energy consumption. Specifically, areas associated with cognitive functions such as memory and attention are metabolic hotspots of intense neural activity. Yet standard connectivity analyses ignore this energetic dimension, treating all regions as functionally equivalent. We introduce the metabolism-weighted connectome (MwC), a framework that maps brain connectivity weighted by each regions energy expenditure. Using simultaneous PET-MRI in healthy volunteers, we show that energetically most active hubs anchor networks for complex cognition, exhibit molecular signatures of intense synaptic activity, and are disproportionately vulnerable to Alzheimers disease. These findings establish a unifying principle: the brain regions most essential for cognition bear the greatest metabolic burden, and this cost may underlie their susceptibility to neurodegeneration.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Ashrafi, M., Fraticelli, L., Castrillon, G., Riedl, V.. 2025-10-02. Metabolism-weighted brain connectome reveals synaptic integration and vulnerability to neurodegeneration. https://doi.org/10.1101/2025.10.02.679973

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

The Unreasonable Effectiveness of Cell Types in Describing Neuronal Physiological Features

Single-cell RNA sequencing (scRNA-seq) captures detailed gene expression profiles at scale, while patch-clamp recordings measure intrinsic neuronal electrophysiological properties. Modeling the relations between these two modalities remains a challenge. Here, we compare how well electrophysiological features can be predicted by traditional transcriptomic cell type classification, representations derived from a foundational model (scGPT) pretrained on large-scale scRNA-seq datasets, ion channel-coding genes, and highly variable genes. Using paired transcriptomic and electrophysiological patch-sequencing data from 495 human neurons from neurosurgical tissue, we find that cluster-level cell type representations consistently outperform highly variable gene selection, ion channel gene selection, and context-enriched scGPT embeddings. Notably, performance varies across model architectures and initializations, and the best results are obtained by combining the outputs of separate cell type and scGPT-based models. Together, these findings suggest that traditional discrete cellular classification is highly effective in predicting physiological features. For maximum performance it can be complemented by pretrained transformer models.

neuroscience↗

A nonlinear inhibition pathway underlying cortical responses to tuned holographic optogenetic perturbations

Optogenetics enables causal manipulation of cortical activity. Perturbation responses can be counterintuitive due to network interactions, making theory essential for predicting them. Existing approaches often rely on linear approximations, which fail for many biologically relevant perturbations. Here we develop a nonlinear theory of responses to holographic perturbations in cell-type-specific recurrent networks with structured connectivity. We fit a nonlinear model to mouse V1 data, which shows cotuned-ensemble suppression: perturbing spatially clustered neurons with similar preferred orientations yields markedly stronger short-range suppression than perturbing untuned ensembles. We show that cotuned-ensemble suppression arises from a feature-tuned, nonlinear inhibition pathway implicating somatostatin-positive (SST) interneurons. The theory predicts that cotuned ensembles suppress parvalbumin-positive (PV) neurons but facilitate SST neurons, and links the degree of cotuned-ensemble suppression or facilitation to the variance of the SST response. This framework identifies mechanisms by which nonlinear inhibition sculpts cortical dynamics and establishes a predictive basis for targeted optogenetic interventions.

neuroscience↗

Proteomic signatures of APOE ε4 across human tissues and cell types in Alzheimers disease

The apolipoprotein E {varepsilon}4 (APOE {varepsilon}4) allele is the strongest genetic risk factor for late-onset Alzheimers disease (AD). However, the underlying molecular mechanisms remain unclear. This study included 1691 participants from the Religious Orders Study and Rush Memory and Aging Project (ROSMAP), 1226 participants from the Accelerating Medicines Partnership - Alzheimers Disease (AMP-AD) Diverse Cohorts Study, and 735 participants from the Alzheimers Disease Neuroimaging Initiative (ADNI). To characterise APOE {varepsilon}4 molecular effects, we analysed proteomic data from plasma, cerebrospinal fluid (CSF), and induced pluripotent stem cell (iPSC)-derived astrocytes and neurons, as well as transcriptomic and proteomic data from multiple brain regions. The association of APOE {varepsilon}4 with AD neuropathology was also examined. APOE {varepsilon}4 carriers shared a plasma proteomic signature enriched for immune processes, irrespective of AD diagnosis. A machine learning classifier trained on this signature discriminated APOE {varepsilon}4 carriers from non-carriers in an independent cohort using CSF proteomics. APOE {varepsilon}4 carriage was associated with higher Braak stages and Consortium to Establish a Registry for Alzheimers Disease (CERAD) score. However, only limited APOE {varepsilon}4-associated transcriptomic and proteomic changes were observed in bulk brain tissue, with poor cross-layer concordance. Proteomic analyses of iPSC-derived astrocytes and neurons further revealed cell-type-specific APOE {varepsilon}4-associated changes. APOE {varepsilon}4 is associated with a consistent proteomic signature across plasma and CSF. Its molecular effects in the brain differ across cell types, brain regions and molecular layers. These findings support the need for cell-type-resolved multi-omic studies to elucidate how APOE {varepsilon}4 confers AD risk.

neuroscience↗